Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pandemic Influenza Vaccine”

240 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 240 results

Early research (Phase 1)WithdrawnNCT00966342
What this trial is testing

Rapid Evaluation of Seasonal Influenza Vaccine

Who this might be right for
Influenza
University of British Columbia 300
Not applicableUnknownNCT04569019
What this trial is testing

Attitudes Towards Influenza Vaccinations Among the Healthcare Workers of Medical University of Warsaw

Who this might be right for
Vaccnation in HCW
Medical University of Warsaw 1,000
Testing effectiveness (Phase 2)Study completedNCT01416571
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults

Who this might be right for
Influenza
GlaxoSmithKline 78
Early research (Phase 1)Study completedNCT01511419
What this trial is testing

Safety Trial of Live Attenuated Influenza (H7N3) Vaccine

Who this might be right for
InfluenzaAvian Influenza
PATH 40
Testing effectiveness (Phase 2)Study completedNCT00771615
What this trial is testing

Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years

Who this might be right for
Influenza
GlaxoSmithKline 469
Post-approval studies (Phase 4)Study completedNCT01001026
What this trial is testing

Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Aboriginal Children and Adults

Who this might be right for
H1N1/2009 Influenza
David Scheifele 156
Early research (Phase 1)Study completedNCT00664417
What this trial is testing

Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine

Who this might be right for
InfluenzaOrthomyxoviridae Infections
Sanofi 375
Early research (Phase 1)Study completedNCT00660257
What this trial is testing

Safety and Immunogenicity of Booster Dose of An Inactivated,Adjuvanted Whole-Virion Pandemic Influenza(H5N1)Vaccine

Who this might be right for
Pandemic Influenza VaccinePreventionPandemic Influenza
Sinovac Biotech Co., Ltd 57
Early research (Phase 1)Study completedNCT00798343
What this trial is testing

Heterosubtypic Immune Responses to Influenza in Older People

Who this might be right for
Influenza
University Hospitals, Leicester 292
Large-scale testing (Phase 3)Study completedNCT02107807
What this trial is testing

Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine

Who this might be right for
Influenza, HumanFlu, HumanFlu, Avian+2 more
Seqirus 539
Early research (Phase 1)Study completedNCT00309647
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of Age

Who this might be right for
Influenza
GlaxoSmithKline 400
Testing effectiveness (Phase 2)Study completedNCT00841646
What this trial is testing

Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects

Who this might be right for
Prepandemic Influenza Vaccine
Novartis Vaccines 343
Not applicableStudy completedNCT00950456
What this trial is testing

Observational Study to Assess Safety of H1N1 Pandemic Influenza Vaccine

Who this might be right for
InfluenzaPandemic Influenza
Alachua Government Services, Inc. 3,216
Post-approval studies (Phase 4)Study completedNCT01002040
What this trial is testing

Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIV

Who this might be right for
HIV InfectionsH1N1 Influenza
University of British Columbia 150
Not applicableStudy completedNCT01763060
What this trial is testing

Long Term Follow up of Patients Who Were Treated With Extracorporeal Membrane Oxygenation for Pandemic Influenza A/H1N1 Induced Severe Respiratory Failure

Who this might be right for
Long Term Outcome
Karolinska University Hospital 7
Testing effectiveness (Phase 2)Study completedNCT01323946
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children

Who this might be right for
Influenza
GlaxoSmithKline 113
Testing effectiveness (Phase 2)Study completedNCT00953524
What this trial is testing

Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi Pasteur, a Sanofi Company 849
Testing effectiveness (Phase 2)Study completedNCT00742885
What this trial is testing

Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine

Who this might be right for
Influenza
GlaxoSmithKline 100
Testing effectiveness (Phase 2)Study completedNCT01666262
What this trial is testing

Phase I/II Safety and Immunogenicity of Pandemic Live Attenuated Influenza Vaccine (PLAIV) Candidate Strain A/17/CA/2009/38 (H1N1) in Healthy Thais

Who this might be right for
Healthy
Mahidol University 363
Testing effectiveness (Phase 2)Study completedNCT01001169
What this trial is testing

Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese Children

Who this might be right for
Influenza
GlaxoSmithKline 60
Next Page